Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if antibiotic resistance of the ocular surface flora to the 4th generation fluoroquinolones will increase after repeated use of topical antibiotics for three days post intravitreal injection.


Clinical Trial Description

Treatment with intravitreal (IVT) injections has increased during the last several years as evidence has accumulated demonstrating the efficacy of anti-vascular endothelial growth factor agents in the treatment of neovascular age-related macular degeneration (AMD) and various retinal vascular diseases. Although IVT injections are generally safe, infectious endophthalmitis is a rare but devastating complication, and the risk of morbidity and vision loss from endophthalmitis is high. The objective is to examine the change in antibiotic resistance of ocular surface flora with repeated prophylactic use of antibiotics after IVT injection for AMD. Yin, V. T., Weisbrod, D. J., Eng, K. T., Schwartz, C., Kohly, R., Mandelcorn, E., Lam, W., Daneman, N., Simor, A., & Kertes, P. J. (2013). Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA ophthalmology, 131(4), 456-461. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01181713
Study type Observational
Source Sunnybrook Health Sciences Centre
Contact
Status Completed
Phase
Start date June 2010
Completion date December 2011

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06044272 - Antimicrobial Resistance in Hospitals From Meta, Colombia
Recruiting NCT06313619 - Decreasing Irrational Antimicrobial Use in Bangladesh: A Digital Intervention Program N/A
Recruiting NCT01408927 - Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population N/A
Completed NCT00771914 - The Effects of Omega-3 Fatty Acids on Aspirin Resistance Phase 1/Phase 2
Completed NCT02708199 - Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic N/A
Completed NCT01718847 - NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors Phase 2
Completed NCT01099943 - Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians N/A